JOHN KIRKWOOD to Monocytes
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Monocytes.
Connection Strength
0.230
-
Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group. J Immunother. 1997 Mar; 20(2):146-57.
Score: 0.119
-
Biologic therapy. Clin Plast Surg. 2000 Oct; 27(4):643-65.
Score: 0.038
-
Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients. J Immunother. 1997 Sep; 20(5):387-98.
Score: 0.031
-
Granulocytopenia in cancer patients treated in a phase I trial with recombinant human tumor necrosis factor. J Immunother (1991). 1991 Apr; 10(2):84-95.
Score: 0.020
-
Effect of intravenous recombinant alpha-2 interferon on monocyte Fc-dependent phagocytosis in patients with malignant melanoma. J Interferon Res. 1984; 4(2):215-21.
Score: 0.012
-
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial. Cancer Chemother Pharmacol. 2002 Dec; 50(6):433-44.
Score: 0.011